MSR41 Matching-Adjusted Indirect Comparison of Amivantamab Vs. Mobocertinib in EGFR Exon 20 Insertion-Mutated Non-Small Cell Lung Cancer
Abstract
Authors
S Van Sanden N Rahhali C Schioppa J Diels B Rodrigues C Chandler V Kapetanakis R Jain T Li